[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ap4m1-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"AP4M1 Gene",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06692712","Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.",[11],"Phase 3","RECRUITING","2026-08-26T02:15:17.167444Z","2026-05-05T02:43:28.971788Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT05518188","Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)",[19],"Phase 1\u002FPhase 2","2026-08-26T02:16:09.452956Z","2026-05-05T02:43:27.979086Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06585605","A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes",[],"2026-08-26T02:17:50.500039Z","2026-06-02T11:21:24.705937Z"]